Simvastatin interaction with clarithromycin and amiodarone causing myositis

被引：13

作者：

Chouhan, UM ^{[1
]}

Chakrabarti, S ^{[1
]}

Millward, LJ ^{[1
]}

机构：

[1] Glan Clwyd Gen Hosp, Conwy & Denbighshire NHS Trust, Dept Pharm, Rhyl LL18 5UJ, Wales

来源：

ANNALS OF PHARMACOTHERAPY | 2005年 / 39卷 / 10期

关键词：

D O I：

10.1345/aph.1G195

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1760 / 1761

页数：2

共 5 条

[1]

*CSM MHRA, 2004, CURRENT PROBLEMS PHA, V30, P1

[2] An examination of the effect of cytochrome P450 drug interactions of hydroxymethylglutaryl-coenzyme a reductase inhibitors on health care utilization: A Canadian population-based study [J].

Einarson, TR ;

Metge, CJ ;

Iskedjian, M ;

Mukherjee, J .

CLINICAL THERAPEUTICS, 2002, 24 (12) :2126-2136

[3] Rhabdomyolysis associated with concomitant use of simvastatin and clarithromycin [J].

Kahri, AJ ;

Valkonen, MM ;

Vuoristo, MKE ;

Pentikäinen, PJ .

ANNALS OF PHARMACOTHERAPY, 2004, 38 (04) :719-719

[4] A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].

NARANJO, CA ;

BUSTO, U ;

SELLERS, EM ;

SANDOR, P ;

RUIZ, I ;

ROBERTS, EA ;

JANECEK, E ;

DOMECQ, C ;

GREENBLATT, DJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :239-245

[5] Rhabdomyolysis in association with simvastatin and amiodarone [J].

Roten, L ;

Schoenenberger, RA ;

Krähenbühl, S ;

Schlienger, RG .

ANNALS OF PHARMACOTHERAPY, 2004, 38 (06) :978-981

← 1 →